$33.76
-0.87-2.51%
At close: Dec 15, 4:00 PM EST
$30.15
-3.61-10.69%
After Hours: Nov 18, 4:09 PM EST
Comments
Loading...
vTv Therapeutics Analyst Ratings and Price Targets | NASDAQ:VTVT | Benzinga
vTv Therapeutics Inc has a consensus price target of $29.25 based on the ratings of 4 analysts. The high is $40 issued by BTIG on November 19, 2025. The low is $6 issued by HC Wainwright & Co. on March 7, 2023. The 3 most-recent analyst ratings were released by BTIG, HC Wainwright & Co., and HC Wainwright & Co. on November 19, 2025, August 13, 2025, and April 9, 2025, respectively. With an average price target of $37.33 between BTIG, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 23.83% upside for vTv Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BTIG
HC Wainwright & Co.
Alliance Global Partners
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for vTv Therapeutics
FAQ
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ:VTVT) was reported by BTIG on November 19, 2025. The analyst firm set a price target for $40.00 expecting VTVT to rise to within 12 months (a possible 32.67% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for vTv Therapeutics (VTVT)?
The latest analyst rating for vTv Therapeutics (NASDAQ:VTVT) was provided by BTIG, and vTv Therapeutics initiated their buy rating.
When was the last upgrade for vTv Therapeutics (VTVT)?
There is no last upgrade for vTv Therapeutics
When was the last downgrade for vTv Therapeutics (VTVT)?
There is no last downgrade for vTv Therapeutics.
When is the next analyst rating going to be posted or updated for vTv Therapeutics (VTVT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of vTv Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for vTv Therapeutics was filed on November 19, 2025 so you should expect the next rating to be made available sometime around November 19, 2026.
Is the Analyst Rating vTv Therapeutics (VTVT) correct?
While ratings are subjective and will change, the latest vTv Therapeutics (VTVT) rating was a initiated with a price target of $0.00 to $40.00. The current price vTv Therapeutics (VTVT) is trading at is $30.15, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
